Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-25
2009-06-09
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S016700, C530S300000, C530S328000
Reexamination Certificate
active
07544666
ABSTRACT:
An oligopeptide comprises formulae (I) or (II)the oligopeptide derivative thereof, and a pharmaceutical composition comprising the same are provided.
REFERENCES:
patent: 4966848 (1990-10-01), Smith et al.
patent: 5223421 (1993-06-01), Smith et al.
patent: 5767240 (1998-06-01), Brenneman et al.
patent: 5837218 (1998-11-01), Peers et al.
patent: 6174862 (2001-01-01), Brenneman
patent: 6613740 (2003-09-01), Gozes et al.
patent: 6933277 (2005-08-01), Brenneman et al.
patent: 2002/0028763 (2002-03-01), Shade et al.
patent: 2002/0111301 (2002-08-01), Brenneman et al.
patent: 2004/0048801 (2004-03-01), Spong et al.
patent: 2004/0053313 (2004-03-01), Gozes et al.
Dementia (Alzheimer's Disease) from the Merck manual.
Parkinsons's disease from the Merck manual.
Brenneman et al., The Journal of Pharmacology and Experimental Therapeutics, 2004, pp. 1190-1197, vol. 309, No. 3.
Zaltzman et al., Neuropharmacology and Neurotoxicology, Mar. 2003, pp. 481-484, vol. 14, No. 3.
Alcalay et al., Neuroscience Letters, 2004, pp. 128-131, 361.
Ashur-Fabian et al., Peptides 24, 2003, pp. 1413-1423.
Beni-Adani et al., The Journal of Pharmacology and Experimental Therapeutics, 2001, pp. 57-63, vol. 296, No. 1.
Blondel et al, The Journal of Neuroscience, Nov. 1, 2000, pp. 8012-8020, 20(21).
Brenneman et al., Biochemical Society Transactions, 2000, pp. 452-455, vol. 28, part 4.
Dicinski et al, The Journal of Biological Chemistry, Jul. 2, 2004, pp. 28531-28538, vol. 279, No. 27.
Furman et al., Neuron Glia Biology, 2005, pp. 1-7, 1.
Gozes et al., Annals New York Academy of Sciences, pp. 115-118.
Gozes et al, Journal of Alzheimer's Disease 6, 2004, pp. 37-41.
Gozes et al., Journal of Molecular Neuroscience, 2000, pp. 61-68, vol. 14.
Gozes et al., Journal of Molecular Neuroscience, 2003, pp. 315-322, vol. 20.
Gozes et al. Journal of Molecular Neuroscience, 2004, pp. 67-72, vol. 24.
Sari et al. Brain Research Reviews, 2006, pp. 1-12, 4C.
Gozes et al, The Journal of Pharmacology and Experimental Therapeutics, pp. 1091-1098, vol. 293, No. 3.
Gozes et al., Trends in Neurosciences, Dec. 2001, pp. 687-690, 700-705, vol. 24, No. 12.
Lagrèze et al., Investigative Ophthalmology & Visual Science, Mar. 2005, pp. 933-938, vol. 46, No. 3.
Leker et al., Stroke, Apr. 2002, pp. 1085-1092.
Pinhasov et al., Developmental Brain Research, 2003, pp. 83-90, vol. 144.
Poggi et al., Department of Obstetrics and Gynecology, Oct. 2002, pp. 973-976, vol. 187, No. 4.
Poggi et al., Department of Obstetrics and Gynecology, Sep. 2003, pp. 790-793, vol. 189, No. 3.
Romano et al., Journal of Molecular Science, 2002, pp. 37-45, vol. 18.
Spong et al., The Journal of Pharmacology and Experimental Therapeutics, 2001, pp. 774-779, vol. 297, No. 2.
Steingart et al., Journal of Molecular Neuroscience, 2000, pp. 137-145, vol. 15.
Visochek et al., The Journal of Neuroscience, Aug. 10, 2005, pp. 7420-7428, 25(32).
Wilkemeyer et al, The Journal of Pharmacology and Experimental Therapeutics, 2004, pp. 1183-1189, vol. 309, No. 3.
Wilkemeyer et al., PNAS, Jul. 8, 2003, pp. 8543-8548, vol. 100, No. 14.
Zaltzman et al., Peptides 26, 2005, pp. 1520-1527.
Zamostiano et al., The Journal of Biological Chemistry, Jan. 5, 2001, pp. 708-714, vol. 276, No. 1.
Zemlyak et al., Peptides 96, 2000, pp. 39-43.
Zusev et al., Peptides 123, 2004, pp. 33-41.
Hu Tsan-Lin
Hwang Chrong-Shiong
Hwang Jenn-Tsang
Lee On
Lin Chiu Hsing
Birch & Stewart Kolasch & Birch, LLP
Ha Julie
Industrial Technology Research Institute
Tsang Cecilia
LandOfFree
NAP derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NAP derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NAP derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4120670